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Abstract
Both solution and solid state nuclear magnetic resonance (NMR) techniques for structural determination are advancing
rapidly such that it is possible to contemplate bringing these techniques to bear upon integral membrane proteins having
multiple transmembrane segments. This review outlines existing and emerging options for model membrane media for use in
such studies and surveys the special considerations which must be taken into account when preparing larger membrane
proteins for NMR spectroscopic studies. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
As the transition is made to the post-genomic era
of biological science, membrane proteins remain one
of the great frontiers of structural and chemical biol-
ogy, particularly when viewed from the standpoint of
what is known about individual molecules. For ex-
ample, there is not a single high resolution structure
available for a G protein-coupled receptor as of mid-
2000. Progress in the area of membrane protein
structural determination has been relatively slow be-
cause of the di⁄culties of applying solution nuclear
magnetic resonance (NMR) spectroscopy and X-ray
crystallographic methods to membrane proteins. This
has provoked innovation in these areas as scientists
¢nd ways to bring these classical methods to bear
upon a greater number of membrane proteins. It
has also led to innovation in the form of non-classi-
cal approaches to structural determination such as
solid state NMR and high resolution electron mi-
croscopy [1].
In this review, we shall not focus upon the details
of NMR spectroscopy. Instead, the focus shall be
upon how appropriate and sometimes innovative
sample preparation methods can enhance the spec-
troscopic accessibility of membrane proteins. Be-
cause of the predisposition of the authors, this review
has been written speci¢cally with NMR spectroscopy
in mind. However, much is applicable or extendible
to other forms of spectroscopy. From a molecular
taxonomic standpoint, the focus of this review is
upon complex integral membrane proteins: proteins
having multiple transmembrane segments, sometimes
with substantial extramembrane domains. It is for
proteins of this class that progress is slowest and,
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from the standpoints of basic and applied biomedical
science, most needed. It is noted with regret that the
scope of this review does not encompass the many
published NMR studies of single-span or peripheral
membrane proteins (cf. [1,2]). Also not covered are
isotopic labeling methods or strategies. In writing
this review, the authors are attempting to address
both NMR experts with little membrane protein ex-
perience and membrane biophysicists with little
NMR experience. It is hoped that specialists in either
area will put up with sections presenting information
which is elementary to them.
It is a presupposition of this review that the ‘gold-
en age’ of NMR as applied to membrane proteins
will arrive in the not so distant future. Solid state
NMR technology is in an extremely rapid phase of
development, such that assignment of the spectra of
relatively small (6 100 residues) proteins now ap-
pears to be within reach for both static sample and
magic-angle-spinning approaches [2^7]. Break-
throughs in solution NMR technology, including
the availability and exploitation of very high mag-
netic ¢elds, have led to the claim that it is now pos-
sible to tackle structural analysis of proteins and
complexes even as large as 100 kDa [8]. This leads
one to contemplate whether it may soon be feasible
to use solution NMR to tackle the three-dimensional
structures of membrane proteins such as the G pro-
tein-coupled receptors (which have seven transmem-
brane spans and whose molecular weights (MW) typ-
ically fall into the 35^50 kDa range [9]).
In general terms, choice of suitable sample condi-
tions for a membrane protein represents a much
more di⁄cult problem than for a water soluble pro-
tein. Consider the case of a soluble protein which one
would like to subject to solution NMR analysis. In
screening for optimal sample conditions, one might
test three temperatures, two salt concentrations and
four values of pH. If all possible combinations are
screened, a total of 3U2U4 = 24 preliminary samples
is required. Now, consider the case of a membrane
protein. In addition to the variables which pertain to
water soluble proteins, one might also want to test
three di¡erent detergent micelle types, each at two
di¡erent detergent concentrations, each in the pres-
ence and absence of added phospholipid. With these
two additional variables, an exhaustive screen of
conditions would require 3U2U4U3U2U2 = 288
di¡erent samples. Thus, optimizing sample condi-
tions for membrane proteins will typically require
either extraordinary fortitude (and the accompanying
resources to support it), combinatorial methods [10],
or well-informed guesses regarding which sample
variables can be safely chosen without systematic
testing. It is the goal of this review to lay out the
full range of membrane-related variables and to re-
view how rational choices can be made which are
most likely to yield positive results in various spec-
troscopic situations.
2. Basic di¡erence between solution NMR and solid
state NMR
‘Solution NMR’ can be de¢ned as the spectrosco-
py of molecules which tumble rapidly and isotropi-
cally on an NMR time scale. Isotropic tumbling
means that the molecule tumbles in three dimensions
in solution such that it has no net average orienta-
tional preference with respect to an imposed mag-
netic ¢eld. Rapid motion on an NMR time scale
means that motions must be faster than the fre-
quency range spanned by relevant static dipolar
and chemical shift tensors. Generally, motions
more rapid than very approximately 200 000 s31
(Hz) will satisfy this condition. Molecules which do
not satisfy the requirements of rapid isotropic mo-
tions fall into the regime of solid state NMR. Note
that molecules such as bilayer lipids may execute
very rapid motions which are not isotropic. Also,
molecules may populate an isotropic distribution of
orientations but fail to execute rapid motional aver-
aging over all orientations (as in powders). Such
molecules behave as solids from an NMR stand-
point.
While a review of NMR methods is not the goal of
this paper, it should be noted that both solid state
and solution NMR can, in principle, be used to e¡ect
total high resolution structural analysis. However,
because the technology of solid state NMR is in a
relatively early state of development relative to solu-
tion NMR, the largest protein whose structure has
been determined to high resolution as of mid-2000 by
solid state NMR is a homodimeric polypeptide of 10
residues per subunit, gramicidin A [4]. This is in con-
trast to solution NMR methods which have been
BBAMEM 77975 10-11-00
C.R. Sanders, K. Oxenoid / Biochimica et Biophysica Acta 1508 (2000) 129^145130
used to solve hundreds of (water soluble) protein
structures, some well in excess of 25 kDa. However,
success to date in applying solution NMR methods
to complex membrane proteins has been modest: the
largest structures determined to high resolution have
only two transmembrane segments and are in the 5^
10 kDa range [11^13]. Moreover, solid state NMR
has at least one tremendous advantage over solution
NMR: methods of this class can be applied to pro-
teins in lipid bilayers.
3. Available model membrane systems
3.1. Vesicles
The variables distinguishing vesicle types from
each other are degree of bilayer multilayering, size,
lipid composition, net charge, shape and lyotropic
phase. A vast literature exists which describes the
preparation and characterization of lipid vesicles
(liposomes) and for reconstituting membrane pro-
teins into them [14^25]. Because even the smallest
vesicles are very large from a solution NMR point
of view (MDa aggregate weights), vesicles are not
used in direct solution NMR studies of integral
membrane proteins [26]. However, they are broadly
employed in solid state NMR. In most cases, large
multilamellar vesicles are used because these are
easily formed and because multilayering makes it
possible to prepare samples with relatively high con-
centrations of lipid and membrane proteins, a fact
which is critical for optimizing NMR signal intensity.
It may be particularly important to choose bilayers
in which the transbilayer thickness matches the span
of the hydrophobic domain of the membrane protein
of interest [27]. Principles for choosing among other
variables for speci¢c experimental situations are de-
scribed in Section 4.
3.2. Native membranes
There are a number of published examples of
NMR studies using samples involving non-puri¢ed
membrane proteins in native membranes. One set
of studies involves titrating membranes rich in the
protein of interest with ligands speci¢c to that pro-
tein. The NMR spectrum of the ligand is monitored.
For solid state NMR, the ligand is generally labeled
with 13C or some other observable heteroatom [28].
Solution NMR studies of the conformation of mem-
brane protein-associated ligand may be possible in
cases where exchange between free (isotropic) ligand
and receptor-bound ligand is rapid on the NMR time
scale. In such cases, transferred nuclear Overhauser
e¡ect (NOE) measurements may be possible ([29], see
also [30]). In this latter regard, it should be noted
that the NOE e¡ect in solids may be extensively
complicated by spin di¡usion: great care should be
exercised in interpreting NOE-like measurements
when the ligand is binding to native membranes or
large vesicles which lie in the solid state regime of
NMR.
A second class of studies involves detection of the
membrane protein itself. This generally requires a
biosynthetic isotopic labeling method. Unless great
care is taken, many other proteins in the membrane
will also be labeled. In some cases, this is not a seri-
ous problem because the protein of interest is in vast
excess to other proteins within a given membrane
preparation as a result of natural or induced over-
expression [28,31^34]. In other cases, double isotopic
labeling schemes and accompanying pulse technology
can be employed to ¢lter out unwanted signals and
to focus upon speci¢c protein sites of interest (for a
solution NMR example of this approach, see [35]).
3.3. Bicelles
Bicelles are ‘binary, bilayered mixed micelles bear-
ing a resemblance to the classical model for bile salt^
phosphatidylcholine aggregates’ [36,37]. Bicelles rep-
resent an intermediate between lipid vesicles and
classical mixed micelles, being composed of phospho-
lipid bilayer discs which are edge-stabilized by an
annulus of detergent. Unlike lipid vesicles, bicelles
do not have inner aqueous compartments and are
optically clear; unlike classical mixed micelles, they
retain a bilayered domain which maintains a number
of key dynamic and conformational properties of
liquid crystalline phase bilayers. Bicelles can be ori-
ented by magnetic ¢elds such that their bilayer nor-
mals are orthogonal to the direction of the applied
¢eld (Fig. 1). It is also known that by doping bicelles
with certain paramagnetic ions, aromatic molecules,
and some membrane proteins, it is possible to change
BBAMEM 77975 10-11-00
C.R. Sanders, K. Oxenoid / Biochimica et Biophysica Acta 1508 (2000) 129^145 131
the sign of aggregate magnetic susceptibility such
that alignment occurs with normals parallel to the
direction of the applied ¢eld (see review in [36]).
The best-characterized bicellar systems are com-
posed of mixtures of dimyristoylphosphatidylcholine
(DMPC) and either dihexanoylphosphatidylcholine
or CHAPSO as the detergent component. For these
mixtures, bicelles form over a fairly wide detergent:
lipid ratio and over a fairly wide range of temper-
atures, but only above the phase transition temper-
ature of the lipid component. There is most likely a
wide range of lipid/detergent type combinations
which will form bicellar assemblies under appropri-
ate conditions.
While the existence and biological relevance of bi-
celle-like aggregates has been appreciated for many
years [38,39], only recently have bicelles been em-
ployed as a medium in which to reconstitute and
characterize integral membrane proteins [40,41]. In
some cases, membrane proteins can be integrated
into bicelles in a manner consistent with maintenance
of the bicellar morphology and with native protein
structure and function. However, it is known that
some membrane proteins interact with bicelles in a
manner such that the aggregate morphology is
grossly perturbed and also that some bicelles disrupt
native folding of some membrane proteins [40,109].
It is quite possible that through continued bicelle
system development, systems may be found which
are compatible with proteins which presently seem
to be incompatible with DMPC-based bicelles. For
example, obvious areas of development include mak-
ing bicelles more like native membranes by using
lipids having longer acyl chains and some degree of
chain unsaturation, by imposing a net negative
charge on bicellar assemblies, and by including
some cholesterol. Work is in progress in these areas
(cf. [42,43]).
Larger bicelles are potentially useful for solid state
NMR studies of membrane proteins. Smaller iso-
tropic bicelles are still much too large to be e¡ec-
tively employed in solution NMR studies of complex
integral membrane proteins. The use of bicelles as a
medium in which to study water soluble proteins is
reviewed in [36].
3.4. Micelles and mixed micelles
Detergent micelles are useful as a medium in which
to solubilize membrane proteins for solution NMR
work because of their relatively small size (usually
10^100 kDa) compared to any available bilayered
Fig. 1. Components and orientational properties of common bicelles. The 2-D cross-section slice models are drawn approximately to
scale (adapted from [36]).
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assemblies. There are, of course, a host of di¡erent
detergent types of varying charges and sometimes
distinctly varying molecular topologies [44^47]. A
number of papers have compared the biochemical
compatibility of various detergent types [48^52].
For NMR experiments, the primary class employed
to date are those having a single polar head group
and a single extended apolar tail type.
Detergent micelles are most often thought of as
spherical assemblies. However, in actuality most mi-
celles (even those formed from only a single deter-
gent type) are probably somewhat cigar-shaped (pro-
late ellipsoid) or discoidal (oblate ellipsoid)
[46,47,53^56]. It should also be kept in mind that
when lipids or proteins are added to micelles, both
the critical micelle concentration (CMC) (the concen-
tration of detergent below which detergent is mono-
meric in solution and beyond which all additional
added detergent forms micelles) and the aggregation
number (the average number of detergent molecules
per micelle) can be perturbed [47,48,50,57,58] some-
times dramatically. This is probably especially true
for membrane proteins when the size of the protein
approaches or exceeds the normal size of the protein-
free micelle. In these cases, it is probably the proper-
ties of the protein which are the primary determinant
of the ¢nal detergent protein aggregate size. For ex-
ample, the 40 kDa diacylglycerol kinase (DAGK)
homotrimer forms 100 kDa protein^detergent mi-
celles with octylglucoside, even though protein-free
octylglucoside micelles are only about 20 kDa [58].
Indeed, for DAGK in a variety of micelle types, it
has been observed that there is little correlation be-
tween the size of detergent^DAGK micelles and the
corresponding protein-free micelles [48].
The term ‘mixed micelles’ usually implies a lipid
component. For micelle size to remain small enough
for solution NMR studies, the lipid:detergent ratio
must remain low. The usual reason for having lipid
present in studies of membrane proteins involving
detergent micelles is to enhance membrane protein
stability and/or functionality. For example, DAGK
is only marginally active in most detergent micelles.
However, when micelles are doped with 5^20 mol%
of various lipids, DAGK’s activity is typically in-
creased by about 50-fold [60,61], such that its speci¢c
activity becomes similar to that in membrane bi-
layers.
3.5. Amphipols
Amphipols are amphipathic polymers which were
recently introduced by Tribet, Audebert and Popot
as a new way of solubilizing membrane proteins in
aqueous solution [62^64]. While many amphipathic
polymers have previously been prepared [65] and
many others can be envisioned, the speci¢c amphi-
pols prepared by Tribet et al. are based upon partial
random amidation of polyacrylic acid with isopro-
pylamine and/or octylamine to generate random
graft co-polymers having MW of 8^35 kDa (Fig.
2). Thus, polar side chains along the polymer back-
bone (i.e. carboxylate) are randomly dispersed with
non-polar side chains (i.e. alkylamides), giving the
polymer an amphipathic character. Because prepara-
tions of polyacrylic acid will contain a range of MW
(distributed around a mean) and because the deriva-
tization of carboxylic acids is partial and random,
any given preparation of amphipols represents a
highly heterogeneous mixture of similar but usually
non-identical molecules.
In principle, a single amphipol molecule can main-
tain the solubility of a single integral membrane pro-
tein in aqueous solution by wrapping itself around
the transmembrane domain such that apolar side
chains of the polymer interact with the protein, while
the polar side chains interact with water and confer
solubility to the complex. Matrix porin (OmpF) from
Escherichia coli has been shown to maintain its tri-
meric structure when complexed by amphipols [62].
In the case of bacteriorhodopsin, it has also been
found that complexation with amphipols does not
seem to perturb its native structure [62]. For exam-
ple, the 14-meric form of cytochrome b6/f solubilized
by amphipol A8-35 or A8-75 molecules has been
shown to retain its ability to catalyze electron trans-
fer reactions [62,64]. The average MW of such a
complex is about 300 kDa compared to 370 kDa
when b6/f is solubilized in mixed micelles.
Amphipols represent a very exciting development
from an NMR point of view because they may ulti-
mately provide a means of solubilizing membrane
proteins for solution NMR which is as good as de-
tergent micelles from the standpoint of maintaining
protein fold and functionality, but which form aggre-
gates of lower e¡ective MW than is possible using
detergent micelles. While not yet extensively tested
BBAMEM 77975 10-11-00
C.R. Sanders, K. Oxenoid / Biochimica et Biophysica Acta 1508 (2000) 129^145 133
for use in NMR experiments, it is possible that the
present class of polyacrylate-based amphipols could
prove to be sub-optimal for NMR of some proteins
because of their anionic nature (which in some cases
might destabilize proteins in a manner analogous
to sodium dodecylsulfate (SDS)) and because of
their molecular heterogeneity. However, even if
these issues do prove problematic, it is highly feasible
that future classes of amphipols can be rationally
fashioned which may eliminate possible draw-
backs.
3.6. Per£uorinated surfactants
Largely through the e¡orts of Jean Riess and his
co-workers, a host of alkyl chain per£uorinated ana-
logues of common lipids and detergents have been
synthesized and characterized [66]. Per£uorinated al-
kanes are even less soluble in water than the corre-
sponding hydrocarbons [67]. As a result, bilayers
formed by chain-per£uorinated lipids are generally
much more stable than the corresponding hydrocar-
bon-based lipids [66,68]. Chain-per£uorinated deter-
gents assemble into micelles, but usually have CMCs
which are about one order of magnitude lower than
hydrocarbon-based detergents of similar chain
lengths [66]. Per£uorocarbons are not very soluble
in hydrocarbons [67,69]. Per£uorocarbon chain al-
kanes have a distinct conformational preference for
sti¡ twisted helical conformations [67] such that the
interiors of bilayers and micelles dominated by these
chains can be expected to have di¡erent properties
than corresponding hydrocarbon assemblies.
It is known that some membrane proteins can be
solubilized using per£uorinated detergents, and that
in some cases native structure may be maintained
[70^73]. It is not generally known whether membrane
proteins are more or less soluble in per£uorinated
phases than in hydrocarbon phases or whether the
native structure can generally be expected to be
maintained. From an NMR standpoint, per£uori-
nated phases have yet to be exploited as a medium
in which to solubilize membrane proteins, but this
possibility is worth pursuing. In this regard, it should
be noted that the cesium salt of per£uorooctanoic
acid (CPO) is known to form bicelle-like assemblies
in which both the bilayer and the micelle-like edge
components of the assemblies are composed exclu-
sively of CPO [74]. Because per£uorocarbons tend
to align in a magnetic ¢eld with their long axes par-
allel to the ¢eld, CPO bicelles orient with their bi-
layer normals parallel to the ¢eld [74]. CPO bicelles
Fig. 2. Solubilization of a hypothetical membrane protein in detergent micelles or in amphipols.
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have been used as a medium for some studies of
membrane-associating polypeptides and lipid mole-
cules [75,76]. It is interesting to speculate that it
may be possible to use per£uorinated phospholipids
which can form bicelles suitable for use with complex
membrane proteins and which may align with bilayer
normals parallel to the ¢eld direction without the
need for additives such as lanthanides.
3.7. Organic solvent mixtures
Complex membrane proteins can often be solubi-
lized in organic solvent mixtures. The concept of
‘naked’ membrane proteins in such mixtures is ap-
pealing for NMR because the e¡ective MW of the
protein is not increased by the association of deter-
gents or other amphiphiles. Girvin and co-workers
have elegantly shown that subunit c of the F1-F0
ATPase (two transmembrane helices with a short
loop connector) adopts a stable, native-like fold in
at least one organic solvent system and have deter-
mined its structure at high resolution [12,13]. How-
ever, one can argue that most complex membrane
proteins cannot be expected to behave as well as
subunit c. While secondary structure may often be
retained, it seems probable that signi¢cant perturba-
tions of protein tertiary structure will usually accom-
pany solubilization by this route. A thorough case
study has been carried out [59] for DAGK (trimer
of 13 kDa subunits, each with three transmembrane
helices). While the authors do not wish to discourage
investigators from trying organic solvent mixtures,
great caution is encouraged.
3.8. A call for creativity
There remain entire classes of detergents which
have been subjected to very little testing for use
with membrane proteins. These include detergents
having non-straight chain saturated hydrocarbon
tails (cf. [77]) and bipolar detergents with two polar
head groups separated by a long connecting apolar
chain. Some of these detergents may have lyotropic
properties which are unique and which may be spec-
troscopically exploitable. They deserve to be tested.
There is also room and impetus for the develop-
ment of novel classes of model membrane media.
Two concepts for how membrane proteins might be
solubilized in low aggregate MW forms are exten-
sions of established strategies. First, there may be
advantages to working with cyclized amphipol-like
molecules. Formally, cyclodextrins fall into this class
(cyclized molecules with a hydrophobic cavity and a
polar surface). However, existing cyclodextrins
[78,79] have cavity diameters which are too small
for more than one transmembrane helix (at the
most). The potential advantages of such cyclized
molecules rather than open chain amphipols include
enhancement of stability for the solubilized protein
and for the protein^polymer complex. A disadvant-
age might be the need to match the polymer cavity
size to that of the protein of interest (if the polymer
is rigid).
A second potential method for solubilizing mem-
brane proteins would be the use of reversed micelles
in very low viscosity organic solvents. Joshua Wand
and co-workers recently demonstrated [80,81] that it
is possible to solubilize water soluble proteins in the
interior of reversed micelles and that when these are
then bathed in a very low viscosity organic solvent
that the tumbling rate of the entire reversed micelle/
protein complex is more rapid than for the protein
alone in water. This is an extremely exciting develop-
ment in solution NMR, promising to help extend the
upper MW limit to total structural analysis by NMR
methods. As of the writing of this review, Wand and
co-workers are working to see if it is possible to
utilize reversed micelles to solubilize membrane pro-
teins for the same purpose. It has previously been
proposed that membrane proteins can be solubilized
such that the two water-exposed domains are encap-
sulated in separate reversed micellar units with the
intervening transmembrane domain being bathed by
the apolar solvent, with the whole complex having a
dumbbell shape [82].
Finally, for no model membrane medium (includ-
ing vesicles) is it presently possible under NMR con-
ditions to impose a stable and constant transmem-
brane voltage, as is present across the membranes of
many living cells. Many membrane proteins are regu-
lated by variations in transmembrane voltage. The
structural consequences of applied transmembrane
voltage and its variations may be profound [83]; it
is possible that some membrane proteins require the
presence of a transmembrane electrical potential to
adopt their physiologically relevant conformation.
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This represents an area which is almost completely
untouched in the realm of high resolution structural
determination because of the technical di⁄culties in
establishing and maintaining such potentials in mod-
el membrane systems within samples appropriate for
NMR or crystallographic experiments. Some prelimi-
nary work in this area has been reported [84,85], but
obstacles remain.
4. Considerations for sample preparation
4.1. Desired orientational state
One family of solid state NMR methods relies
upon the use of samples in which molecules are uni-
formly aligned, usually parallel to the direction of the
magnetic ¢eld. The net degree of molecular align-
ment of lipid vesicles with normals parallel to the
¢eld can be quite high if vesicles can be forced to
adopt a pancake shape. There are two methods for
accomplishing this. First, multilamellar vesicles can
be sandwiched between glass plates which are often
then stacked [86^88]. The vesicles are forced to ‘pan-
cake’ between the plates by shear/mechanical forces
such that the vast majority of bilayer normals are
aligned perpendicular to the plates. A second method
relies upon the use of an ultracentrifuge to prepare
essentially £at and uniformly aligned multilamellae
through controlled centrifugal forces [89].
Bicelles represent an alternate method of achieving
model membrane alignment. In order to achieve the
parallel alignment of the bicelle normals with respect
to the ¢eld that is required for studies of complex
integral membrane proteins (for reasons described in
[36]), it is necessary to change the sign of aggregate
magnetic susceptibility for the bilayered discs. This
can be accomplished by doping the bicelles with cer-
tain lanthanide ions, with lanthanide ion^lipid che-
late complexes, or certain aromatic molecules [36].
Of these mechanisms, the use of the lanthanide/lipid
chelates may be the most biochemically compatible
[90,91]. In some cases, the presence of the membrane
protein alone may be adequate to e¡ect the change in
sign of susceptibility [92,93]. One potential advantage
of bicelles is that they can easily be employed in li-
gand titration experiments, unlike the case of me-
chanically aligned bilayers.
4.2. Motion and solid state NMR
Solid state NMR studies of membrane proteins
will normally be carried out in bilayers (native mem-
branes, vesicles or bicelles). A range of di¡erent
(non-isotropic) aggregate and molecular motions
may be present in some samples, with each motion
having its own rate and amplitude. Some of these
motions can result in serious problems for solid state
NMR. When motional frequencies are similar to the
frequencies spanned by anisotropic spin tensors or
pulse radiofrequency ¢elds, resonance line broaden-
ing and/or reduced signal to noise may result from
interference or intermediate exchange a¡ects [94^
100]. Accordingly, motion should be regarded as an
important experimental variable which will often
need to be managed in order to acquire quality solid
state NMR data. Fortunately, strategies exist for ex-
perimentally modulating motions in membrane sys-
tems.
Liquid crystalline phase bilayers (at temperatures
above Tm) are highly dynamic environments and
generally permit both whole-protein axial rotation
about the bilayer normal and, most likely, whole-
protein wobbling and local conformational dynamics
[14,101^103]. Bilayer domain undulations may also
be present in some cases [15]. Below Tm, bilayers
adopt the highly ordered semi-crystalline gel phase
where both lipid and protein dynamics are dramati-
cally dampened. When the temperature is lowered
still further, sample freezing can be induced and mo-
tions can be dampened further. Alternately, samples
may be freeze-dried. It is possible that when working
with freeze-dried samples or low temperature hy-
drated samples that it may sometimes prove advanta-
geous to employ additives (such as cryoprotectants)
to reduce potentially disruptive phenomena resulting
from bilayer dehydration or ice crystal formation
[104,105]. The conformational states of bilayer lipid
and constituent membrane proteins can be a function
of the freezing method employed. In principle, by
very rapid freezing of liquid crystalline phase sam-
ples, it may be possible to preserve in ‘snap-shot’
form the heterogeneous conformational states of
the liquid crystalline phase at low temperatures
[106,107]. This is in contrast to samples prepared
by slower freezing, where proteins and lipids will
(ideally) anneal into their thermodynamically pre-
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ferred conformational states determined by the ¢nal
temperature.
The presence of lipids having distinct topologies
and dynamics such as cholesterol [108], glycolipids
[97,98] or cardiolipin may also be used to provide
some degree of modulation of protein motions in
bilayers.
At the present state of technology, bicelles have a
disadvantage with respect to vesicular systems in that
they form an uncharacterized isotropic phase below
the Tm of the lipid component. Preliminary experi-
ments to freeze samples so that bicelle morphology
and orientation is maintained at low temperatures
have been described [109], but work in this area re-
mains in an early stage of development. It should
also be noted that whole-bicelle wobbling motions
likely occur, but that the typical amplitudes and rates
are not known. Such motion is yet another potential
source of spectroscopic line broadening.
4.3. Motion and solution NMR
Overall protein^amphiphile aggregate tumbling is
rapid and isotropic within micelles, detergent-rich
mixed micelles and amphipols. However, protein
conformational motions may vary considerably
from system to system. It is quite likely that when
proteins are removed from the quasi-two-dimension-
al (2-D) environment of a lipid bilayer and solubi-
lized in a more disordered environment such as that
of a detergent micelle, that internal protein confor-
mational motions may be dramatically enhanced
(Fig. 3). Crudely, one might think of this phenomen-
on in terms of the protein acquiring some degree of
‘molten globular’ [110,111] character. This may be a
disadvantage, particularly if the amplitudes of such
motions are large and/or if the rates for such motions
are on an intermediate NMR time scale. This can
lead to serious spectroscopic problems including
loss of spectral dispersion, dramatic line broadening
and loss of observable NOE transfers between nor-
mally proximal spin pairs. The presence of such
motions may be minimized in some cases by employ-
ing detergents known to be mild to proteins, by
using lipid-containing mixed micelles in which
protein^lipid interactions may enhance maintenance
of native-like structure, and by adding ligands (such
as substrates or inhibitors if the protein is an en-
zyme) which may bind and thereby stabilize the pro-
tein.
There are examples of complex membrane proteins
for which high quality NMR spectra have been ac-
quired in micelles or organic solvents, but for which
structural determination has yet to be achieved [112^
114]. In some of these cases, it is likely that the
proteins under examination adopt their correct sec-
ondary structure, but do not have stable tertiary
structures. Thus, while high quality spectra may be
acquired and possibly even assigned, long range
NOEs may not be observed, making structural deter-
mination very di⁄cult. This suggests that when seek-
ing to acquire NMR data demonstrating feasibility
of structural determination for membrane proteins,
observation of long range NOEs should be regarded
as a critical test.
4.4. Consistency with protein fold, function and
stability
As human observers, it seems very obvious that
some model membrane systems better mimic the
structural, dynamic and morphological properties
of native bilayers than others. In general, the resem-
blance to native membranes decreases in the order:
vesicless bicellessmixed micellessmicelless am-
phipols. However, from the standpoint of a mem-
brane protein under spectroscopic conditions, what
matters most is the degree to which a given system
mimics native membranes in terms of maintaining a
protein’s native conformational, dynamic and func-
tional state (Fig. 3). From this point of view, even
micelles may in some cases represent perfectly re-
spectable model membrane systems. Accordingly,
when possible, assessment of speci¢c conditions
should be made from the speci¢c protein’s point of
view. This can be accomplished fairly easily for pro-
teins having a function which can be speci¢cally as-
sayed under spectroscopic sample conditions. For
example, enzyme activity can typically be measured
regardless of the model membrane medium used.
This has been a powerful tool in the case of
DAGK [48,59]. However, even in such favorable
cases results are sometimes ambiguous. If an en-
zyme’s activity in a particular medium is 50% of
the known activity in native membranes, does one
interpret this observation as re£ecting a ‘signi¢cant
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perturbation’ of native structure or as re£ecting ‘only
minor perturbation’? In this case, additional charac-
terization beyond activity measurement is required to
establish the validity of structural studies.
For some classes of proteins in some media, func-
tional assay is not possible. For example, channel
activity cannot be assessed in micelles. In such cases,
evidence for native structure must be acquired
through indirect methods such as measurement of
ligand binding capacity (for example, a channel
may have a site for an allosteric e¡ector) or testing
for native oligomeric state. Evidence for or against
maintenance of native state may also be acquired in
the form of structural ‘¢nger-prints’ using methods
such as chemical modi¢cation rate measurements,
chemical cross-linking, amide H^D exchange mea-
surements, or spectroscopic methods such as near-
UV circular dichroism or tryptophan-based £uores-
cence. In these cases, the goal is to compare structur-
ally sensitive data acquired for the protein under
conditions in which it is known to be correctly folded
(but which may be unsuitable for NMR) to spectra
acquired under the NMR-relevant conditions. In this
regard, it should be pointed out that methods which
yield the degree of protein secondary structure (far-
UV CD and FT-IR) must be used with particular
care, since unfolded or misfolded membrane proteins
often retain the same secondary structure composi-
tion as in the native fold [59,115^117]. The possibility
that the protein may adopt a ‘molten globule’-like
structural state which re£ects the functional fold,
but in which there are considerable conformational
dynamics not present in the true native structural
state of the protein, must also be taken into account
(Fig. 3).
Thermodynamic protein stability (Fig. 3) is pri-
marily of relevance to the question of whether a pro-
tein can be considered to be properly folded under
spectroscopic conditions or whether the unfolded
population in equilibrium exchange with the folded
population is high enough that NMR data analysis is
complicated (see end of Section 4.2). Assessment of
the thermodynamic stability of complex membrane
proteins is not trivial. Bowie and co-workers have
shown that SDS can be used as a denaturant in ti-
trations of at least one micellar membrane protein,
leading to denaturation curves akin to those typically
obtained for water soluble proteins using urea or
Fig. 3. Undesired fates for a hypothetical membrane protein in model membrane media (membrane-mimetic phases not shown).
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guanidine hydrochloride [116]. Di¡erential scanning
calorimetry has also been applied to a number of
membrane proteins [115].
Kinetic protein instability typically leads to the
formation of irreversibly aggregated, un- or mis-
folded protein with time (Fig. 3). This is a particu-
larly worrisome phenomenon in cases where very
long NMR experiments are required, sometimes at
elevated temperatures. Such instability is often de-
tectable in the form of a visible aggregate, in the
form of loss of NMR signal intensity with time, or
in the appearance of unexpected peaks with time. In
general, conditions which promote a protein’s ther-
modynamic stability will promote kinetic stability,
but this is not always true.
From a practical sample preparative standpoint,
¢nding conditions in which protein stability is en-
hanced and maintained over long periods of time
involves optimizing the usual parameters of pH,
ionic strength and temperature. Choice of speci¢c
model membrane media (for example detergent
type) is also critical, as is the amphiphile:protein
ratio. Some detergents are general protein denatur-
ants and should usually be avoided, including SDS
and N-laurylsarcosine [48]. The presence of lipid in
mixed micelles can often enhance stability (e.g. [60]).
As noted earlier, ligands speci¢c for the protein of
interest may be employed to enhance stability.
Bowie and co-workers have recently shown that it
is possible to use mutagenesis methods to dramati-
cally enhance both the thermodynamics and kinetic
stability of DAGK in detergent micelles [118,119]. If
this approach can be generally and simply applied to
most membrane proteins, this represents an exciting
development in the practical structural biology of
membrane proteins.
4.5. Avoidance and correction of protein misfolding
Distinct from the stability issues described above is
the potential that preparations of membrane proteins
may be plagued by a population of protein which is
stably folded, but which has adopted a fold which is
not the native (usually thermodynamically preferred)
conformational state of the protein (Fig. 3). Such
misfolding may occur at the point of protein expres-
sion and folding in vivo or could occur at some point
during protein puri¢cation and/or reconstitution.
This phenomenon appears to be related to a number
of diseases [120^125]. The presence of this problem
for a given protein may not be easy to detect. In the
case of DAGK, misfolding appears to be a serious
problem and can occur both during or prior to pu-
ri¢cation and during the process of reconstitution
[126]. For DAGK, symptoms include irreproducible
catalytic speci¢c activities (U/mg) from batch to
batch of puri¢ed protein, irreversible activity loss
following reconstitutions into vesicles by some meth-
ods, and observation of aberrant oligomeric states
for the micelle- and vesicle-solubilized protein.
Avoiding misfolding altogether may be di⁄cult if
this occurs for the protein of interest at the stage of
biosynthesis. Misfolding which occurs during protein
puri¢cation is likely to be highly protein-speci¢c;
however, key variables are likely to include choices
of methods for lysing and extracting cell membranes,
and choices of bu¡ers and detergents used during
puri¢cation steps.
Methods have been forwarded for correcting mem-
brane protein misfolding [126^129]. The ¢rst involves
the use of protein denaturants (i.e. urea) in the pres-
ence of detergent to unfold misfolded protein bound
to an a⁄nity column, followed by the removal of
that detergent and refolding into a native-like con-
formational state [127]. A second method which has
been found to be very e¡ective in the case of DAGK
is known as ‘reconstitutive refolding’ [126]. This
method requires that the membrane protein is puri-
¢ed into dodecylphosphocholine micelles. At this
stage, misfolding is still present. However, when the
lipid POPC is mixed with the DAGK-DPC micelles
followed by dialytic removal of DPC to form
DAGK/POPC vesicles, refolding of misfolded
DAGK occurs. The proper fold persists even if the
vesicles are redissolved into detergent micelles. This
process requires the speci¢c DPC/POPC combina-
tion; other lipid/detergent mixtures tested did not
work. That many DAGK mutants could be refolded
by this method was evident through observation of a
dramatic increases in catalytic activities (measured
under identical assay conditions before and after re-
folding) and through correction of previously aber-
rant oligomeric states following the refolding proce-
dure [126].
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4.6. Attainable protein concentration and sample
heterogeneity
NMR is a notoriously insensitive technique such
that it is generally necessary to conduct experiments
with ‘apparent’ protein concentrations of at least
1 mM. We refer to ‘apparent’ concentration because
for a membrane protein in model membranes, the
critical concentration of the protein from thermody-
namic and solubility standpoints will often be the
concentration of the protein within the membrane-
mimetic phase. This can be described in units of vol-
ume fraction (volume of membrane protein/total vol-
ume protein and model membrane) or mol fraction
(mol of membrane protein/total mol of membrane
protein+amphiphile). It can easily be shown that
the probability of collision of two 10 kDa protein
molecules in solution at 1 mM concentration is
much lower than the probability for collision of
two 10 kDa membrane proteins at a concentration
of 1 mM in micelles or bilayers where the detergent
or lipid concentration is 100 mM. Thus, at NMR-
accessible apparent concentrations of membrane pro-
teins, the probability may be high that in-membrane
solubility limits will be exceeded or that aberrant
oligomerization could take place (Fig. 3). There are
several possible ways of keeping these problems at
bay. One is to work at the highest possible lipid:pro-
tein or detergent:protein ratios (often referred to as
‘surface dilution’). Another is to optimize the com-
position of the membrane-mimetic phase or of the
aqueous phase in a fashion designed to suppress
non-speci¢c protein^protein interactions. Finally,
there may be protein modi¢cations which can be
made to suppress non-speci¢c aggregation or oligo-
merization (e.g. attachment of polyethylene glycol).
In addition to possible sample heterogeneity result-
ing from the undesired presence of protein aggregate
or oligomers at high concentrations, there is another
serious problem in the case of detergent micelles.
Situations may exist where some micelles may have
only one protein molecular per micelle while others
may have more than one. Not only will the proteins
in the ‘multiple protein micelles’ have a high propen-
sity for aggregation, but they may yield a much
broader set of signals than the protein from ‘single
protein micelles’ or may even yield a completely dif-
ferent set of signals (distinct chemical shifts). This
problem has been nicely identi¢ed and addressed
by Opella and co-workers [130]. The solution they
proposed is to work under conditions where the mi-
celle concentration is much higher than the apparent
protein concentration. The micelle concentration can
be estimated as (total detergent concentra-
tion3CMC)/aggregation number. By way of exam-
ple, if a detergent forms micelles with an aggregation
number of 100, one should work at a much higher
concentration than (100 mM+CMC) if the desired
apparent protein concentration is 1 mM. There
may be some proteins for which there is not an ad-
vantage to working at very high detergent concen-
trations (for reasons unknown). For example, we
have found that the NMR spectral quality of
DAGK is not detectably enhanced at high micelle
concentrations (unpublished).
In the cases of bicelles and lipid bilayers used in
solid state NMR, the number of protein molecules
per membrane-mimetic unit will often be of less con-
cern because the dimensions of the individual model
membrane units are much larger than individual pro-
tein molecules. A more serious problem in frozen or
dehydrated samples may be the conformational mi-
croheterogeneity of the protein of interest. Each con-
formation can yield its own distinct spectrum. When
many conformations are present, individual compo-
nents will usually not be resolved, but peaks may be
very broad due to the overlap of spectra from the
individual conformers. For this reason, it may some-
times be preferable to work with protein microcrys-
tals (if available) or protein which has been carefully
precipitated with agents such as ammonium sulfate
or polyethylene glycol. While these methods are pres-
ently being explored for solid forms of water soluble
proteins in several labs (e.g. [131], and unpublished
work from several labs), this represents an unex-
plored area for membrane proteins.
4.7. Getting the protein from native membranes into
a desired sample state and concentrating
protein^detergent mixtures
Extracting a membrane protein from native bi-
layers, purifying it and reconstituting it into a model
membrane medium suitable for NMR experiments
generally involves a number of transfers from one
medium to another. While the possible methods for
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accomplishing this are legion, it should be pointed
out that the use of chromatographic resins to which
puri¢ed protein can be reversibly bound is ideally
suited for NMR sample preparation. In our lab, we
have observed that when polyhistidine-tagged mem-
brane DAGK is bound to a Ni(II)-agarose metal ion
chelate resin, it is possible to then reequilibrate the
protein on the column with a host of di¡erent sol-
vent conditions including: micelles (various detergent
types), amphipols, detergent^lipid mixed micelles, de-
naturants (e.g. 6 M urea) and even organic solvent
mixtures (Fig. 4). The protein can then be eluted in
any of these solutions using 0.5% formic acid, 0.3 M
imidazole or 0.5 M ammonium hydroxide
([48,59,132], Sanders, unpublished). Such methods
are ideal when using perdeuterated detergents be-
cause reequilibration and elution can be accom-
plished with a minimal volume of (expensive) solu-
tion being required. In principle, all membrane
proteins should be amenable to sample preparation
using an analogous approach employing ion ex-
change chromatography, even without an engineered
puri¢cation tag such as polyhistidine.
Once a protein is in a suitable model membrane
system at a suitable protein:amphiphile ratio, it is
often desirable to uniformly concentrate both the
protein and the model membranes. The ‘usual’ meth-
ods applied to water soluble proteins can often be
applied to membrane proteins. These include freeze-
drying/rehydration, centrifugal or pressure-based ul-
tra¢ltration, and bu¡er removal through dialysis tub-
ing in contact with impermeant hygroscopic poly-
mers. Large protein/lipid vesicles can generally be
concentrated by pelletting using an ultracentrifuge.
It should be kept in mind for ultra¢ltration tech-
niques that it is usually only the bu¡er which is re-
moved. While monomeric detergent can pass through
ultra¢ltration membranes, unless the CMC is high
relative to the total detergent concentration, the
amount which is removed during concentration pro-
cedures will typically be negligible unless repeated
concentration/redilution (with detergent-free bu¡er)
cycles are executed.
Selective removal of detergent from protein^lipid
micellar mixtures to concentrate the protein in terms
of the protein:detergent ratio can, of course, be ac-
complished by dialysis of the protein^detergent solu-
tion versus a detergent-free solution. Detergent re-
moval occurs through escape of the constantly
replenished monomeric detergent population in equi-
librium with the impermeant detergent^protein mi-
celles. Of course, dialysis should be halted prior to
complete detergent removal or membrane protein ag-
gregation and precipitation will occur. Because of
osmotic swelling inside the dialysis compartment,
the bulk protein concentration is usually lowered
somewhat following partial detergent removal by
this method.
Protein vesicle formation can be accomplished by
a host of reconstitution methods, most of which in-
volve the mixing of micellar protein with lipid, fol-
lowed by detergent removal to induce vesicle forma-
tion. Depending on the exact method and conditions
of detergent removal, di¡erent classes of vesicles
(large vs. small, unilamellar vs. multilamellar) will
form [14,16^18,22,23]. It should be pointed out that
structural integrity of some membrane proteins can
Fig. 4. Use of metal ion chelate a⁄nity chromatography as a
£exible route to membrane protein samples for NMR. The pro-
tein illustrated is hypothetical, but all of the options illustrated
in this ¢gure have been applied in the Sanders lab to DAGK
(homotrimer of 13 kDa subunits, each with three transmem-
brane segments).
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be disrupted by some procedures. Sometimes this is
not surprising. For example, when active DAGK in
multilamellar vesicles is extruded repeatedly through
¢lters to generate unilamellar vesicles, it is denatured,
presumably by the shear forces (Sanders, unpub-
lished). DAGK is also denatured when large vesicles
are subjected to high power sonication. Of course,
membrane proteins are notoriously ¢nicky and in
many cases much trial and error may be required
to generate a correctly folded protein sample in
vesicles having desired characteristics for any given
experiment.
4.8. Suitability of lipid vesicles for ligand titration
experiments
The case of lipid vesicles represents a special chal-
lenge to NMR experiments in which measurements
are made as the membrane protein is titrated with
membrane-impermeant ligands. In such cases, the li-
gand cannot freely access protein sites located on the
interior of unilamellar or multilamellar vesicles.
However, it has been demonstrated that if vesicles
are subjected to multiple rapid freeze/thaw proce-
dures, complete equilibration of impermeant ligands
occurs [133,134]. Apparently, freeze/thawing transi-
ently fractures or lyses membranes permitting tran-
sient permeability. Of course, one must always be
concerned about whether the membrane protein of
interest can functionally/structurally tolerate such re-
petitive freeze/thaw procedures.
4.9. Is perdeuteration of the membrane-mimetic phase
necessary in solution NMR experiments?
Because solution NMR studies of complex mem-
brane proteins will typically be carried out with 15N-
and/or 13C-labeled protein, the now routine use of
13C- or 15N-based isotopic ¢ltering NMR pulse
methods makes it possible to avoid the use of expen-
sive perdeuterated detergents in order to eliminate
what would otherwise be an intense set of signals
from the protons on the detergent. Nevertheless,
there remain reasons why it may sometimes be desir-
able to employ perdeuterated detergents. First, for
large detergent^protein complexes, the use of perdeu-
terated detergent will eliminate any possible spin dif-
fusion pathways between protein and detergent
peaks which could lead to spurious NOE-like cross-
peaks between non-proximal spin pairs [135]. Sec-
ondly, use of perdeuterated detergents will eliminate
possible line broadening of protein resonances due to
relaxation through the 1H^1H dipolar relaxation
mechanism [135,136]. Third, in cases where very
high detergent concentrations are used, use of per-
deuterated detergent will eliminate possible 1H sig-
nals from the detergent under conditions of 13C iso-
topic ¢ltering because the natural abundance 13C
concentration is signi¢cant for the concentrated de-
tergent component. Fourth, there are some pulse se-
quences in which spectral ¢ltering to remove the de-
tergent peaks occurs not during individual scans, but
rather through resonance cancellations for multiple
scans di¡ering in associated phase cycling. In such
cases, the receiver gain cannot be set very high be-
cause of the size of the detergent signal present in
individual scans. This leads to sub-optimal sensitiv-
ity. Finally, any time there are huge unwanted sig-
nals which must be eliminated by a pulse sequence,
there is the probability that the ¢ltering method will
be imperfect, and that artifacts will show up in the
¢nal multidimensional spectrum, sometimes in very
compromising positions. The actual degree to which
the above concerns translate into real problems has
not been well-examined, but such concerns should be
borne in mind until there is consensus based on
broad experience.
Only a limited number of detergents are commer-
cially available in perdeuterated form. Of those avail-
able in mid-2000, one can make the case that dode-
cylphosphocholine is the most suitable for most
applications based on its structural similarity to the
lipid phosphatidylcholine, its biochemical compati-
bility, the high degree to which its micelles have pre-
viously been characterized, the fact that it is known
to actually promote refolding when used to reconsti-
tute at least one membrane protein, and its extensive
prior utilization in NMR studies of transmembrane
and surface-associated polypeptides [48,126,137^
140].
Acknowledgements
We thank Drs. S. Opella (and his lab), J. Preste-
gard, S. Prosser, L. Thompson, M. Keyes, D. Gray,
BBAMEM 77975 10-11-00
C.R. Sanders, K. Oxenoid / Biochimica et Biophysica Acta 1508 (2000) 129^145142
D. Ca¢so, S. Smith, M. Cocco, J.-L. Popot, J. Wand,
J. Bowie, M. Hong and F. Soennichsen for helpful
discussion related to various topics covered in this
review. This work was supported by the US National
Institutes of Health (Grants R21 GM59071, R43
DK49911 and RO1 GM47485).
References
[1] S.H. White, Membrane Protein Structure: Experimental Ap-
proaches, Oxford University Press, New York, 1994.
[2] F.M. Marassi, S.J. Opella, Curr. Opin. Struct. Biol. 8 (1998)
640^648.
[3] M. Hong, J. Biomol. NMR 15 (1999) 1^14.
[4] R. Fu, T.A. Cross, Ann. Rev. Biophys. Biomol. Struct. 28
(1999) 235^268.
[5] C.M. Reinstra, M.E. Hatcher, L.J. Mueller, B. Sun, S.W.
Fesik, R.G. Gri⁄n, J. Am. Chem. Soc. 120 (1998) 10602^
10612.
[6] J.H. Davis, M. Auger, Prog. NMR Spectr. 35 (1999) 1^84.
[7] F.M. Marassi, C. Ma, J.J. Gesell, S.J. Opella, J. Magn.
Reson. 144 (2000) 156^161.
[8] G. Wider, K. Wuthrich, Curr. Opin. Struct. Biol. 9 (1999)
594^601.
[9] S. Watson and S. Arkinstall, The G-Protein Coupled Recep-
tor Facts Book, Academic Press, San Diego, CA, 1994.
[10] J. Armstrong, A. De Lencastre, E. Gouax, Protein Sci. 8
(1999) 1475^1483.
[11] K.R. MacKenzie, J.H. Prestegard, D.M. Engelman, Science
276 (1997) 131^133.
[12] M.E. Girvin, V.K. Rastogi, F. Abildgaard, J.L. Markley,
R.H. Fillingame, Biochemistry 37 (1998) 8817^8824.
[13] V.K. Rastogi, M.E. Girvin, Nature 402 (1999) 263^268.
[14] R.B. Gennis, Biomembranes: Molecular Structure and
Function, Springer-Verlag, New York, 1989.
[15] M. Bloom, E. Evans, O.G. Mouritsen, Q. Rev. Biophys. 24
(1991) 293^397.
[16] J.R. Silvius, Ann. Rev. Biophys. Biomol. Struct. 21 (1992)
323^348.
[17] T.D. Maden, Chem. Phys. Lipids 40 (1986) 207^222.
[18] R.A. Cerone, E.M. Ross, Methods Enzymol. 195 (1991)
329^342.
[19] R.P. Rand, V.A. Persegian, Biochim. Biophys. Acta 988
(1989) 351^376.
[20] D.D. Lasic, Biochem. J. 256 (1988) 1^11.
[21] A. Walter, in: B.P. Gaber and K.R.K. Easwaran (Eds.),
Biomembrane Structure and Function ^ The State of the
Art, Adenine Press, New York, 1992, pp. 21^35.
[22] J.-L. Rigaud, D. Levy, G. Mosser, O. Lambert, Eur. Bio-
phys. J. 27 (1998) 305^319.
[23] J.-L. Rigaud, B. Pitard, D. Levy, Biochim. Biophys. Acta
1231 (1995) 223^246.
[24] D.W. Deamer and P.S. Uster, in: M.J. Ostro (Ed.), Lipo-
somes, Marcel Dekker, New York, 1985, pp. 27^51.
[25] M. Ca¡rey, LIPDAT on-line database, http://lipdat.chemis-
try.ohiostate.edu/.
[26] G.D. Henry, B.D. Sykes, Methods Enzymol. 239 (1994) 515^
535.
[27] J.A. Killian, Biochim. Biophys. Acta 1376 (1998) 401^416.
[28] A. Watts, A.S. Ulrich, D.A. Middleton, Mol. Membr. Biol.
12 (1995) 233^246.
[29] O.G. Kisselev, J. Kao, J.W. Ponder, Y.C. Fann, N. Gautam,
G.A. Marshall, Proc. Natl. Acad. Sci. USA 95 (1998) 4270^
4275.
[30] B.W. Koenig, D.C. Mitchell, S. Konig, S. Grezesiek, B.J.
Litman, A. Bax, J. Biol. NMR 16 (2000) 121^125.
[31] J.M. Gri⁄ths, K.V. Lakshmi, A.E. Bennett, J. Raap, C.M.
van der Wielen, J. Lugtenberg, J. Herzfeld, R.G. Gri⁄n,
J. Am. Chem. Soc. 116 (1994) 10178^10181.
[32] S. Yamaguchi, S. Tuzi, T. Seki, M. Tanio, R. Needleman,
J.K. Lanyi, A. Naito, H. Saito, J. Biochem. 123 (1998) 78^
86.
[33] J. Wang, Y.S. Balasz, L.K. Thompson, Biochemistry 36
(1997) 1699^1703.
[34] S.O. Smith, K. Aschheim, M. Groesbeek, Q. Rev. Biophys.
29 (1996) 395^449.
[35] M. Seigneuret, M. Kainosho, FEBS Lett. 327 (1993) 7^12.
[36] C.R. Sanders, R.S. Prosser, Structure 6 (1998) 1227^1234.
[37] C.R. Sanders, B.J. Hare, K.P. Howard, J.H. Prestegard,
Prog. NMR Spectr. 26 (1994) 421^444.
[38] N.A. Mazer, G.B. Benedek, M.C. Carey, Biochemistry 19
(1980) 601^615.
[39] D.M. Small, Gastroenterology 52 (1967) 607^610.
[40] C.R. Sanders, G.C. Landis, Biochemistry 34 (1995) 4030^
4040.
[41] K.P. Howard, S.J. Opella, J. Magn. Reson. B 112 (1996) 91^
94.
[42] S.M. Gerber, G.A. Lorigan, K.P. Howard, J. Am. Chem.
Soc. 121 (1999) 3240^3241.
[43] J. Struppe, E.A. Komives, S.S. Taylor, R.R. Vold, Biochem-
istry 37 (1998) 15523^15527.
[44] J. Neugebauer, A Guide to the Properties and Uses of De-
tergents in Biology and Biochemistry, Calbiochem Biochem-
icals, La Jolla, CA, 1988.
[45] Products Catalog, Anatrace Inc., Maumee, OH, 2000.
[46] M.K. Jain, Introduction to Biological Membranes, 2nd edn.,
John Wiley and Sons, New York, 1988.
[47] D. Lichtenberg, R.J. Robson, E.A. Dennis, Biochim. Bio-
phys. Acta 737 (1983) 285^304.
[48] O. Vinogradova, F. Sonnichsen, C.R. Sanders, J. Biomol.
NMR 4 (1998) 381^386.
[49] M.E. Womack, D.A. Kendall, R.C. MacDonald, Biochim.
Biophys. Acta 733 (1983) 210^215.
[50] J.R. Casey, R.A. Reithmeier, Biochemistry 32 (1993) 1172^
1179.
[51] P. Banerjee, J.B. Joo, J.T. Buse, G. Dawson, Chem. Phys.
Lipids 77 (1995) 65^78.
BBAMEM 77975 10-11-00
C.R. Sanders, K. Oxenoid / Biochimica et Biophysica Acta 1508 (2000) 129^145 143
[52] J. Kessi, J.-C. Poiree, E. Wehrli, R. Bachofen, G. Semenza,
H. Hauser, Biochemistry 33 (1994) 10825^10836.
[53] J. Herzfeld, Acc. Chem. Res. 29 (1996) 31^37.
[54] D.M. Small, The physical chemistry of lipids, in: D.J.
Hanahan (Ed.), Handbook of Lipid Research, Vol. 4,
1986.
[55] C. Tanford, The Hydrophobic E¡ect: Formation of Micelles
and Biological Membranes, 2nd edn., John Wiley and Sons,
New York, 1980.
[56] T.-L. Lin, S.-H. Chen, M.F. Roberts, J. Am. Chem. Soc. 109
(1987) 2321^2328.
[57] M.A. Hink, A. van Hoek, A.J.W.G. Visser, Langmuir 15
(1999) 992^997.
[58] J.V. Moller, M. le Maire, J. Biol. Chem. 268 (1993) 18659^
18672.
[59] O. Vinogradova, P. Badola, L. Czerski, F. Sonnichsen, C.R.
Sanders, Biophys. J. 72 (1997) 2688^2701.
[60] J.P. Walsh, R.M. Bell, J. Biol. Chem. 261 (1986) 15062^
15069.
[61] P. Badola, C.R. Sanders, J. Biol. Chem. 272 (1997) 24176^
24182.
[62] C. Tribet, R. Audebert, J.-L. Popot, Proc. Natl. Acad. Sci.
USA 93 (1996) 15047^15050.
[63] C. Tribet, R. Audebert, J.-L. Popot, Langmuir 13 (1997)
5570^5576.
[64] C. Tribet, D. Mills, M. Haider, J.-L. Popot, Biochimie 80
(1998) 475^482.
[65] R.S. Velichkova, D.C. Christova, Prog. Polym. Sci. 20
(1995) 819^887.
[66] M.P. Kra¡t, J.G. Riess, Biochemie 80 (1998) 489^514.
[67] B.E. Smart, in: R.E. Banks (Ed.), Organo£uorine Chemis-
try: Principles and Commercial Applications, Plenum Press,
New York, 1994, pp. 57^88.
[68] T.J. McIntosh, S.A. Simon, P. Vierling, C. Santaella, V.
Ravily, Biophys. J. 71 (1996) 1853^1868.
[69] P. Mukerjee, T. Handa, J. Phys. Chem. 85 (1981) 2298^2303.
[70] E. Chabaud, P. Barthelemy, N. Mora, J.-L. Popot, B. Pucci,
Biochemie 80 (1998) 515^530.
[71] F.H. Shepherd, A. Holzenberg, Anal. Biochem. 224 (1995)
21^27.
[72] M. Ramjeesingh, L.-J. Huan, E. Garami, C.E. Bear, Bio-
chem. J. 342 (1999) 119^123.
[73] M. Ramjeesingh, C. Li, E. Garami, L.J. Huan, M. Hewryk,
Y. Wang, K. Galley, C.E. Bear, Biochem. J. 327 (1997) 17^
21.
[74] N. Boden, P.H. Jackson, K. McMullen, M.C. Holmes,
Chem. Phys. Lett. 65 (1979) 476^479.
[75] A. Kimura, T. Kano, H. Fujiwara, J. Magn. Reson. B 112
(1996) 44^50.
[76] A. Kimura, N. Kuni, H. Fujiwara, J. Phys. Chem. 100
(1996) 14056^14061.
[77] Anatrace Product Catalog, Anatrace Inc., World Wide Web:
http://www.anatrace.com, Maumee, OH, 1999.
[78] V.T. D’Souza, K.B. Lipkowitz, Chem. Rev. 98 (1998) 1741^
1742.
[79] J. Szejtl, Chem. Rev. 98 (1998) 1743^1754.
[80] A.J. Wand, M.R. Ehrhardt, P.F. Flynn, Proc. Natl. Acad.
Sci. USA 95 (1998) 15299^15302.
[81] M.R. Ehrhardt, P.F. Flynn, A.J. Wand, J. Biomol. NMR
14 (1998) 75^78.
[82] M. Montal, in: P.L. Luisi and B. Straub (Eds.), Reverse
Micelles, Plenum Press, New York, 1984, pp. 220^221.
[83] T.Y. Tsong, R.D. Astumian, Prog. Biophys. Mol. Biol. 50
(1987) 1^45.
[84] P. Osman, B.A. Cornell, Biochim. Biophys. Acta 1195
(1994) 197^204.
[85] E. Perozo, W.L. Hubbell, Biochemistry 32 (1993) 10471^
10478.
[86] R.S. Prosser, S.A. Hunt, R.R. Vold, J. Magn. Reson. B 109
(1995) 109^111.
[87] S.J. Opella, Y. Kim, P. McDonnell, Methods Enzymol. 239
(1994) 536^560.
[88] F. Moll, T.A. Cross, Biophys. J. 57 (1990) 351^362.
[89] G. Grobner, A. Taylor, P.T.F. Williamson, G. Choi, C.
Glaubitz, J.A. Watts, W.J. de Grip, A. Watts, Anal. Bio-
chem. 254 (1997) 132^138.
[90] R.S. Prosser, V.B. Volkov, I.V. Shiyanovskaya, Biophys. J.
75 (1998) 2163^2169.
[91] R.S. Prosser, H. Bryant, R.G. Bryant, R.R. Vold, J. Magn.
Reson. 414 (1999) 256^260.
[92] B.W. Koenig, J.-S. Hu, M. Ottiger, S. Bose, R.W. Hendler,
A. Bax, J. Am. Chem. Soc. 121 (1999) 1385^1386.
[93] C.J.A. Van Echteld, B. De Kruij¡, A.J. Verkleij, J. Jeunis-
sen-Bijvelt, J. De Gier, Biochim. Biophys. Acta 692 (1982)
126^138.
[94] D.E. Warschawski, J.D. Gross, R.G. Gri⁄n, J. Chim.
Phys. 95 (1998) 460^466.
[95] D.C. Maus, V. Copie, B. Sun, J.M. Gri⁄ths, R.G. Gri⁄n,
S. Luo, R.R. Schrock, A.H. Liu, S.W. Seidel, W.M. Davis,
A. Grohmann, J. Am. Chem. Soc. 118 (1996) 5665^5671.
[96] S.O. Smith, I. Palings, V. Copie, D.P. Raleigh, J. Courtin,
J.A. Pardoen, J. Lugtenberg, R.A. Mathies, R.G. Gri⁄n,
Biochemistry 26 (1987) 1606^1611.
[97] E. Old¢eld, F. Adebodun, J. Chung, B. Montez, K.D.
Park, H.-B. Le, B. Phillips, Biochemistry 30 (1991)
11025^11028.
[98] F. Adebodun, J. Chung, B. Montez, E. Old¢eld, X. Shan,
Biochemistry 31 (1992) 4502^4509.
[99] R. Voelkel, Angew. Chem. Int. Ed. Eng. 27 (1988) 1468^
1483.
[100] D.L. VanderHart, W.L. Earl, A.N. Garroway, J. Magn.
Reson. 44 (1981) 361^401.
[101] P.L. Yeagle, in: P.L. Yeagle (Ed.), The Structure of Bio-
logical Membranes, CRC Press, Boca Raton, FL, 1992, pp.
157^174.
[102] R.J. Cherry, in: P.L. Yeagle (Ed.), The Structure of Bio-
logical Membranes, CRC Press, Boca Raton, FL, 1992, pp.
507^537.
[103] R.L. Smith, E. Old¢eld, Science 225 (1984) 280^288.
[104] D.L. Jakeman, D.J. Mitchell, W.A. Shuttleworth, J.N.S.
Evans, J. Biomol. NMR 12 (1998) 417^421.
[105] C.W.B. Lee, S.K. Das Gupta, J. Mattai, G.G. Shipley,
BBAMEM 77975 10-11-00
C.R. Sanders, K. Oxenoid / Biochimica et Biophysica Acta 1508 (2000) 129^145144
O.H. Abdel-Mageed, A. Makriyannis, R.G. Gri⁄n, Bio-
chemistry 28 (1989) 5000^5009.
[106] N.D. Lazo, W. Lee, K.C. Lee, T.A. Cross, Biochem. Bio-
phys. Res. Commun. 197 (1993) 904^909.
[107] N.D. Lazo, W. Hu, T.A. Cross, J. Magn. Reson. B 107
(1995) 43^50.
[108] M. Bloom, Phys. Can. 48 (1992) 7^16.
[109] R.S. Prosser and C.R. Sanders, in: J. Katsaras and T.
Gutberlet (Eds.), Lipid Bilayers, Springer-Verlag, New
York, 2000 (in press).
[110] Y. Wang, D. Shortle, Biochemistry 34 (1995) 15895^15905.
[111] B.A. Schulman, P.S. Kim, C.M. Dobson, C. Red¢eld, Nat.
Struct. Biol. 4 (1997) 630^634.
[112] M. Schwaiger, M. Lebendiker, H. Yerushalmi, M. Coles,
A. Groger, C. Schwarz, Eur. J. Biochem. 2554 (1998) 610^
619.
[113] I.A. Grabchuk, V.Y. Orekhov, A.S. Arseniev, Pharm. Acta
Helv. 71 (1996) 97^102.
[114] V.Y. Orekhov, G.V. Abdulaeva, L.Y. Musina, A.S. Arsen-
iev, Eur. J. Biochem. 210 (1992) 223^229.
[115] T. Haltia, E. Freire, Biochim. Biophys. Acta 1241 (1995)
295^322.
[116] F.W. Lau, J.U. Bowie, Biochemistry 36 (1997) 5884^5892.
[117] P.J. Booth, A.R. Curran, Curr. Opin. Struct. Biol. 9 (1999)
115^121.
[118] F.W. Lau, S. Nauli, Y. Zhou, J.U. Bowie, J. Mol. Biol. 290
(1999) 559^564.
[119] F. Zhou, J.U. Bowie, J. Biol. Chem. 275 (2000) 6975^6979.
[120] M. Jung, I. Sommer, M. Schachner, J. Neurosci. 16 (1996)
7920^7929.
[121] K.D. Ridge, Z. Lu, X. Liu, H.G. Khorana, Biochemistry 34
(1995) 3261^3267.
[122] F.S. Seibert, T.W. Loo, D.M. Clarke, J. Bioenerg. Bio-
membr. 29 (1997) 429^442.
[123] A.F. Goldberg, C.J. Loewen, Biochemistry 37 (1998) 680^
685.
[124] P.J. Thomas, B.H. Qu, P.L. Pedersen, Trends Biochem. Sci.
20 (1995) 456^459.
[125] C.R. Sanders, J.K. Nagy, Curr. Opin. Struct. Biol. 10
(2000) 438^442.
[126] B.M. Gorzelle, J.K. Nagy, K. Oxenoid, W. Lonzer, D.S.
Ca¢so, C.R. Sanders, Biochemistry 38 (1999) 16373^
16382.
[127] H. Rogl, K. Kosemund, W. Kuhlbrandt, I. Collinson,
FEBS Lett. 432 (1998) 21^26.
[128] S.K. Buchanan, Curr. Opin. Struct. Biol. 9 (1999) 455^
461.
[129] R. Grisshammer, C.G. Tate, Q. Rev. Biophys. 28 (1995)
315^522.
[130] P.A. McDonnell, S.J. Opella, J. Magn. Reson. B 102 (1993)
120^125.
[131] Z. Gu, D.G. Druekhammer, L. Kurz, K. Liu, D.P. Martin,
A. McDermott, Biochemistry 38 (1999) 8022^8031.
[132] C.R. Sanders, L. Czerski, O. Vinogradova, P. Badola, D.
Song, S.O. Smith, Biochemistry 35 (1996) 8610^8618.
[133] L.D. Mayer, M.J. Hope, P.R. Cullis, A.S. Jano¡, I. West-
man, Y. Boulanger, A.I. Ehrenberg, I.C.P. Smith, Biochim.
Biophys. Acta 685 (1982) 315^328.
[134] J. Westman, Y. Boulanger, A. Ehrenberg, I.C.P. Smith,
Biochim. Biophys. Acta 685 (1982) 315^328.
[135] M. Sattler, S.W. Fesik, Structure 4 (1996) 1245^1249.
[136] L. Kay, K. Gardner, Ann. Rev. Biophys. Biomol. Struct. 27
(1998) 357^406.
[137] J. Lauterwein, C. Bosch, L.R. Brown, K. Wuthrich, Bio-
chim. Biophys. Acta 556 (1979) 244^264.
[138] L.R. Brown, Biochim. Biophys. Acta 557 (1979) 135^
148.
[139] V. Beswick, R. Guerois, F. Cordier-Oschsenbein, Y.-M.
Coic, T. Huynh-Dinh, J. Tostain, J.-P. Noel, A. Sanson,
J.-M. Neumann, Eur. Biophys. J. 28 (1998) 48^58.
[140] D.A. Kallick, M.R. Tessmer, C.R. Watts, C.-Y. Li,
J. Magn. Reson. B 109 (1995) 60^65.
BBAMEM 77975 10-11-00
C.R. Sanders, K. Oxenoid / Biochimica et Biophysica Acta 1508 (2000) 129^145 145
